Functional classification of left ventricular remodelling: prognostic relevance in myocardial infarction
Surenjav Chimed1, Pieter van der Bijl1, Rodolfo Lustosa1
1Department of Cardiology, Heart and Lung Centre, Leiden University Medical Centre, Albinusdreef 2, Leiden, 2300 RC, The Netherlands.
Insights
This study reclassified left ventricular (LV) remodelling after ST-segment elevation myocardial infarction (STEMI) by including LV function. Patients with LV remodelling and impaired ejection fraction (EF) had significantly worse outcomes, improving risk stratification.
Area of Science:
- Cardiology
- Clinical Research
- Medical Diagnostics
Background:
- Current post-ST-segment elevation myocardial infarction (STEMI) left ventricular (LV) remodelling definitions focus solely on structural changes (dilatation).
- LV function, specifically ejection fraction (EF), is a known predictor of long-term outcomes post-STEMI.
- Integrating functional parameters into remodelling classification may enhance prognostic accuracy.
Purpose of the Study:
- To reclassify LV remodelling after STEMI by incorporating both LV dilatation and LVEF.
- To investigate the prognostic implications of this integrated functional LV remodelling classification.
- To assess if functional remodelling improves risk stratification beyond structural changes alone.
Main Methods:
- Retrospective analysis of STEMI patients treated with primary percutaneous coronary intervention (PCI).
- Patients were categorized into four subgroups based on LV dilatation and LVEF impairment.
- Outcomes including mortality and heart failure hospitalization were analyzed over a median follow-up of 76 months.
Main Results:
- A total of 2346 patients were studied.
- Patients with both LV remodelling and impaired LVEF exhibited significantly lower survival rates (P < 0.001).
- Event-free survival rates were also significantly lower in the group with LV dilatation and LVEF impairment (P < 0.001).
Conclusions:
- A functional LV remodelling classification improves risk stratification compared to structural remodelling alone.
- Identifying patients with the worst prognosis through functional assessment enables early preventative therapies.
- This approach offers a more comprehensive understanding of post-STEMI cardiac changes and patient outcomes.
Aims:
The current definition of post ST-segment elevation myocardial infarction (STEMI) left ventricular (LV) remodelling is purely structural (LV dilatation) and does not consider LV function (ejection fraction, EF), even though it is known to be a predictor of long-term post-STEMI outcome. This study aimed to reclassify LV remodelling after STEMI by integrating LV dilatation and function (LVEF) and to investigate the prognostic implications.
Methods And Results:
Data from an ongoing registry of STEMI patients who were treated with primary percutaneous coronary intervention (PCI) were retrospectively evaluated. Four distinct remodelling subgroups were identified: (i) no LV dilatation, no LVEF impairment,(ii) no LV dilatation but LVEF impairment, (iii) LV dilatation but no LVEF impairment, and (iv) LV dilatation and LVEF impairment. The impact of functional LV remodelling on outcomes was analysed. A total of 2346 patients were studied (mean age 60 ± 11 years, 76% men). During a median follow-up of 76 (interquartile range 52 to 107) months, 282 (12%) died, while the composite of death and heart failure hospitalization occurred in 305 (13%) patients. Those with LV remodelling and LVEF impairment had a significantly lower survival rate (P < 0.001) and event-free survival rate (P < 0.001) compared with other functional LV remodelling groups.
Conclusions:
Employing a functional LV post-infarct remodelling classification has the potential to improve risk stratification beyond structural LV remodelling alone. Identification of patients with the worst prognosis by using a functional LV remodelling approach may allow institution of early preventative therapies.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure


